Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers of Influenza Infectivity (PRESAGE)
NCT03207152Phase 1Unknown
- Sponsor
- Duke University
- Start
- Sep 2017
- Primary completion
- May 2018
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Influenza A (IAV), sponsored by Duke University. Primary endpoint: Viral load at 28 days. Status: unknown.
02
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT03207152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03207152.